APA (7th ed.) Citation

T, S., SWT, H., WF, O., C, X., M, X., N, P., . . . P, T. (2021). Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer. Genome medicine, 13(1), 158. https://doi.org/10.1186/s13073-021-00970-3

Chicago Style (17th ed.) Citation

T, Sheng, et al. "Integrative Epigenomic and High-throughput Functional Enhancer Profiling Reveals Determinants of Enhancer Heterogeneity in Gastric Cancer." Genome Medicine 13, no. 1 (2021): 158. https://doi.org/10.1186/s13073-021-00970-3.

MLA (9th ed.) Citation

T, Sheng, et al. "Integrative Epigenomic and High-throughput Functional Enhancer Profiling Reveals Determinants of Enhancer Heterogeneity in Gastric Cancer." Genome Medicine, vol. 13, no. 1, 2021, p. 158, https://doi.org/10.1186/s13073-021-00970-3.